Iovance Biotherapeutics (IOVA) Inventory (2023 - 2026)

Iovance Biotherapeutics (IOVA) has reported Inventory for 4 consecutive years, with $58.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Inventory fell 10.94% year-over-year to $58.4 million; the TTM figure through Mar 2026 stood at $58.4 million (down 10.94% YoY), while the FY2025 annual figure was $51.7 million, changed 0.31% from the prior year.
• Inventory advanced to $58.4 million in Q1 2026 per IOVA's latest filing, from $51.7 million in the prior quarter.
• Across five years, Inventory topped out at $65.5 million in Q1 2025 and bottomed at $9.2 million in Q3 2023.
• Historically, Inventory has averaged $37.6 million across 4 years, with a median of $50.7 million in 2024.
• Annual changes were most pronounced in 2024 — Inventory jumped 396.72% — and 2026, when it fell 10.94%.
• Iovance Biotherapeutics' Inventory stood at $10.4 million in 2023, then soared by 396.72% to $51.5 million in 2024, then increased by 0.31% to $51.7 million in 2025, then rose by 12.96% to $58.4 million in 2026.
• Business Quant data shows IOVA's Inventory at $58.4 million in Q1 2026, $51.7 million in Q4 2025, and $51.7 million in Q3 2025.